CSCs identified from human brain and colon cancer express CSC cell surface marker CD133 and have the capacity to self-renew and differentiate, while CD133-tumor cells lack tumorigenicity [75,76,77]. This evidence concerns the gene PROM1 and colonic neoplasm.